Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7WXK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,861
Award facts
- Contract value 100% obligated
- $14,860.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,860.80 to AmerisourceBergen Drug Corp for the supply of Beyfortus 50 mg/0.5 mL syringes on January 22, 2026. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 23, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. Beyfortus is a respiratory syncytial virus (RSV) monoclonal antibody indicated for prevention of RSV lower respiratory tract disease in infants and young children.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 2031. This single-award IDC serves as a global pharmaceutical support vehicle enabling the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract demonstrates AmerisourceBergen's established capability as a critical pharmaceutical distributor to federal medical procurement, particularly serving the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7WXK?
SPE2DR26F7WXK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F7WXK worth?
The government has obligated $14,861 on SPE2DR26F7WXK.
Is contract SPE2DR26F7WXK an order under another contract?
Yes. SPE2DR26F7WXK is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WXK competed?
The extent of competition for SPE2DR26F7WXK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award